February 14, 2019
G47Δ, an oncolytic virus granted the sakigake fast-track designation, delivered strong efficacy data in an investigator-initiated trial enrolling patients with glioblastoma, a type of malignant brain tumor, the University of Tokyo and the Japan Agency for Medical Research and Development...read more